...
首页> 外文期刊>PDA journal of pharmaceutical science and technology >Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts
【24h】

Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts

机译:防止冻干过程中的交叉污染:GMP和非产品的职业清洁要求和间接产品 - 接触部件

获取原文
获取原文并翻译 | 示例

摘要

A detailed overview is provided for the possible patient exposure to highly potent active pharmaceutical ingredients (HPAPIs) from potential cross-contamination through the lyophilization process. The intent of this paper is to raise awareness of the risk(s) to patients and stimulate the implementation of adequate risk-based controls, such as containment process(es), use of adequate surrogates in cleaning validation/verification, and test method-sensitivity-based cleaning validation acceptance conditions. Although lyophilizers are considered to be nonproduct-contact surfaces because their surfaces and fixtures do not usually come into direct contact with the product, product contamination can occur at critical locations within a lyophilizer and/or during the unloading process. Contamination of the air because of released product particles can also create a risk. Therefore, special attention should be paid to HPA-PIs, as the permitted daily exposures (PDEs) for patients are particularly low. During a lyophilizer cycle, areas of concern are spreading of the lyophilizer HPAPI powder because of air turbulence, contaminated plates, mechanical transfer systems, and spreading because of damaged vials or contaminated stainless steel or plastic surfaces. Specific considerations for contamination containment for the lyophilizer unloading process are presented. Suggestions are provided for the prevention of patient exposure through cross-contamination via direct-contact areas and prevention of manufacturing personnel exposure via non-direct-contact areas. A surface limit(s) of 1 PDE per square decimeter for nonproduct-contact surfaces inside a lyophilizer is proposed. Risk-based cleaning validation/verification strategies are discussed, with specific consideration of the quality control test method sensitivity expectations and use of suitable surrogates for lyophilized products in the cleaning verification studies.
机译:提供了通过冻干过程的潜在交叉污染的可能患者暴露于高效的活性药物成分(HPAPI)提供详细的概述。本文的目的是提高对患者的风险的认识,并刺激遏制过程的适当风险控制,例如遏制过程,在清洁验证/验证中使用适当的代理,以及测试方法 - 基于灵敏度的清洁验证验收条件。虽然冻干器被认为是非产物 - 接触表面,因为它们的表面和夹具通常不会与产品直接接触,但产品污染可能会在冻干器内的关键位置和/或在卸载过程中发生。由于释放的产品颗粒而污染空气也可以产生风险。因此,应特别注意HPA-PIS,因为患者的允许的日常暴露(PDE)特别低。在冻干循环期间,由于空气湍流,污染的板,机械转移系统以及由于损坏的小瓶或受污染的不锈钢或塑料表面而散布,所关注的区域是冻干剂HPAPI粉末的扩散。提出了对冻干器卸载过程的污染抑制填充过程的具体考虑因素。通过通过直接接触区域通过交叉污染预防患者暴露以及通过非直接接触区域预防制造人员暴露的建议提供了建议。提出了一种用于冻干器内的非产品接触表面的每平方排2的1 PDE的表面限量。讨论了基于风险的清洁验证/验证策略,具体考虑了质量控制试验方法敏感性预期和使用合适的替代品在清洁验证研究中使用合适的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号